Expansion in intracerebral hematoma

Area of Science:

• Neurology
• Neurosurgery
• Emergency Medicine

Background:

• Intracerebral hemorrhage (ICH) remains a stroke subtype lacking primary therapeutic interventions.
• Current research explores targeting specific pathological events like hemorrhage expansion, mass effect, or inflammation.
• This pilot study investigated the efficacy of antifibrinolytic drugs in stabilizing hematoma expansion in ICH patients.

Discussion:

• A sequential cohort design was employed, with a control group (n=9) and an e-aminocaproic acid treated group (n=5).
• The control group exhibited a 22% rate of hematoma expansion (HE).
• The treated group showed a 60% HE rate, suggesting e-aminocaproic acid was ineffective for clot stabilization.

Key Insights:

• Antifibrinolytic therapy with e-aminocaproic acid did not appear to limit early hematoma expansion in ICH.
• The observed increase in HE rate in the treated group raises concerns about the drug's efficacy in this context.
• The study was terminated early due to futility, as determined by the institutional review board.

Outlook:

• Further research is needed to identify effective treatments for intracerebral hemorrhage.
• Alternative therapeutic strategies targeting different mechanisms of ICH progression should be explored.
• The findings underscore the complexity of ICH management and the limitations of current antifibrinolytic approaches.